Another study independently confirmed that CXCR4 antagonism with plerixafor (AMD3100) enhances T cell infiltration by releasing trapped CXCR4-expressing T cells in CXCL12-rich stroma before reaching carcinoma cells (Feig et al. 2013). Here, CXCR4 is linked to carcinoma.